Erratum: Comparison study of [18F]FAl-NOTA-PRGD2, [ 18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice (Bioconjugate Chemistry (2011) 22:12 (2415-2422) DOI: 10.1021/bc200197h);Comparison study of [18F]FAl-NOTA-PRGD2, [18F] FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of u87mg tumors in mice

Bioconjugate Chemistry

Volumn 22, Issue 12, 2011, Pages 2415-2422

  Lang, Lixin ^a   Li, Weihua ^a   Guo, Ning ^a   Ma, Ying ^a   Zhu, Lei ^a   Kiesewetter, Dale O ^a   Shen, Baozhong ^a   Niu, Gang ^a,b   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM COMPOUNDS; FLUORINE COMPOUNDS; IMAGE PROCESSING; PEPTIDES; PHARMACOKINETICS;

ALUMINUM COMPLEXES; ANGIOGENESIS; BIOCONJUGATES; CLINICAL TRIAL; COMPARISON STUDY; IMAGING PROPERTIES; INTEGRIN RECEPTORS; PET IMAGING; PROPERTY; SYNTHETIC PROCEDURES;

TUMORS;

2 (4 ISOTHIOCYANATOBENZYL) 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID PEGYLATED DIMERIC RGD PEPTIDE F 18; 2 (4 ISOTHIOCYANATOBENZYL) 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID PEGYLATED DIMERIC RGD PEPTIDE GA 68; PEGYLATED DIMERIC RGD PEPTIDE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; DIAGNOSTIC AGENT; FLUORINE; GALLIUM; HETEROCYCLIC COMPOUND; OLIGOPEPTIDE;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; DRUG DISTRIBUTION; DRUG PURIFICATION; DRUG STABILITY; DRUG UPTAKE; GLIOBLASTOMA; IC 50; ISOTOPE LABELING; KIDNEY CLEARANCE; MOUSE; NONHUMAN; SOLID PHASE EXTRACTION; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; HUMAN; METHODOLOGY; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; TUMOR CELL LINE;

ANIMALIA; MUS;

ANIMALS; CELL LINE, TUMOR; FLUORINE RADIOISOTOPES; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; HUMANS; MICE; NEOPLASMS; OLIGOPEPTIDES; POSITRON-EMISSION TOMOGRAPHY;

EID: 84555177937     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200673p     Document Type: Erratum

References (29)

1. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285, 1182-6
2. Stupack, D. G. and Cheresh, D. A. (2004) Integrins and angiogenesis Curr. Top. Dev. Biol. 64, 207-38 (Pubitemid 39752398)
3. Niu, G. and Chen, X. (2011) Why integrin as a primary target for imaging and therapy Theranostics 1, 30-47
4. Beer, A. J., Kessler, H., Wester, H.-J., and Schwaiger, M. (2011) PET imaging of integrin αvβ3 expression Theranostics 1, 48-57
5. Zhou, Y., Chakraborty, S., and Liu, S. (2011) Radiolabeled cyclic RGD peptides as radiotracers for imaging tumors and thrombosis by SPECT Theranostics 1, 58-82
6. Morrison, M. and Cuthbertson, A. (2011) Integrin imaging to evaluate treatment response Theranostics 1, 149-153
7. 18F-FDG PET of response to Abraxane therapy J. Nucl. Med. 52, 140-6
8. 121/rGel treatment Mol. Pharm. 8, 621-628
9. Yang, M., Gao, H., Yan, Y., Sun, X., Chen, K., Quan, Q., Lang, L., Kiesewetter, D., Niu, G., and Chen, X. (2011) PET imaging of early response to the tyrosine kinase inhibitor ZD4190 Eur. J. Nucl. Med. Mol. Imaging 38, 1237-1247
10. 99mTc-labeled Arg-Gly-Asp (RGD) peptide in rats with ischemic acute renal failure J. Am. Soc. Nephrol. 7, 2682-8
11. 111In-labeled RGD-peptide targeting integrin αvβ3 in a preclinical tumor model Cancer Biother. Radiopharm. 23, 691-700
12. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis Nucl. Med. Biol. 31, 179-89 (Pubitemid 38315112)
13. 64Cu-labeled dimeric RGD peptides Mol. Imaging Biol. 6, 350-9 (Pubitemid 39243068)
14. 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice J. Nucl. Med. 49, 830-6
15. 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression Eur. J. Nucl. Med. Mol. Imaging 35, 1100-8
16. 89Zr-RGD Peptides. Mol. Imaging Biol., Dec 16. [Epub ahead of print]
17. 111In- labeled RGD peptide Nucl. Med. Biol. 34, 29-35 (Pubitemid 46038156)
18. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression Mol. Imaging Biol. 12, 530-8
19. 18F]FPPRGD2: An automated multi-step radiosynthesis for clinical PET studies. Mol. Imaging Biol., Mar 12. [Epub ahead of print]
20. 18F-FRGD2 J. Nucl. Med. 47, 113-21 (Pubitemid 46768520)
21. Jacobson, O., Zhu, L., Ma, Y., Weiss, I. D., Sun, X., Niu, G., Kiesewetter, D. O., and Chen, X. (2011) Rapid and simple one-step F-18 labeling of peptides Bioconjugate Chem. 22, 422-8
22. 68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging Eur. J. Nucl. Med. Mol. Imaging 36, 947-57
23. 18F labeling of peptides with a fluoride-aluminum-chelate complex Bioconjugate Chem. 21, 1331-40
24. 18F radiolabeling for PET J. Nucl. Med. 50, 991-8
25. Jacobson, O. and Chen, X. (2010) PET designated flouride-18 production and chemistry Curr. Top. Med. Chem. 10, 1048-59
26. 18F]-fluorobenzene for PET Bioconjugate Chem. 20, 817-23
27. 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks Bioconjugate Chem. 19, 1871-9
28. 18F-radiolabeling of peptides for PET imaging Angew. Chem., Int. Ed. Engl. 47, 4922-5
29. 18F-fluorine J. Nucl. Med. 51, 454-61